E Ochodo, Stellenbosch University, Evidence synthesis for building a translation pipeline to eliminate infectious diseases
Lead Research Organisation:
Liverpool School of Tropical Medicine
Department Name: Clinical Sciences
Abstract
Infectious diseases such as HIV, tuberculosis (TB) and malaria still cause considerable illness and death in Africa. This is despite malaria and TB being treatable, the availability of tests to detect these diseases and the presence of treatment to normalize the health of people living with HIV. One possible explanation for this could be the ineffective ways used to implement or translate findings of research to inform policy. Research translation involves getting the right information to the right people at the right format they can easily understand to inform decision-making. A policy that is implemented too rapidly or too slowly can minimize effective control of disease. Getting this right is important and needs rigorous methods and science to help assure this.
Summarizing available research findings and presenting it in a way that can be easily interpreted and understood (otherwise known as evidence synthesis) can help in decision making. Multiple influencing factors exist between the decision to use an intervention and its use in practice. A portfolio of integrated research findings from different fields including technical aspects, costs, acceptability and practicality is needed but methods of integration are still unclear. Our vision is a broader base of research findings for implementation being supported by summarising research findings from different fields to inform policy, implementation and revisions of policies.
In Africa, there has been limited research and development on methods to improve how research findings are summarised and how to improve translation of research findings to policy. Research methods tailored to the African context are needed to facilitate better uptake and sustainability in the region.
This project aims to formally develop an approach to translating research findings into policy through summarizing and integrating research findings from different fields. We also aim to recommend methods of improving translation of evidence into policy. Ultimately, through this, we aim to establish a research group and in future a sub-regional centre for the science of evidence synthesis and research translation in Kenya. To our knowledge such a directive or coordinating centre does not yet exist in Kenya.
The objectives of this project are:
1. To summarize the effect and delivery of new and existing interventions on HIV, TB and malaria per national priorities of Kenya.
2. To develop and implement methods of summarizing and integrating research findings and knowledge from different fields.
3. To develop summaries of reviews generated by summarizing and integrating research and knowledge.
4. To communicate and circulate know-how and products of this integrative approach to policy makers.
In the process of achieving this, we will establish a research group in evidence synthesis and research translation in HIV, TB and malaria in Kenya.
This project is timely and has potential for great impact. Under new leadership, there is an explicit shift in the World Health Organization (WHO) to devolve policy making to regional level. The future requires the position of control for evidence synthesis to be firmly implanted in the research infrastructure in Africa. The findings of this project will be useful to policy makers in Kenya who require capacity to integrate research findings from different areas when making decisions.
Summarizing available research findings and presenting it in a way that can be easily interpreted and understood (otherwise known as evidence synthesis) can help in decision making. Multiple influencing factors exist between the decision to use an intervention and its use in practice. A portfolio of integrated research findings from different fields including technical aspects, costs, acceptability and practicality is needed but methods of integration are still unclear. Our vision is a broader base of research findings for implementation being supported by summarising research findings from different fields to inform policy, implementation and revisions of policies.
In Africa, there has been limited research and development on methods to improve how research findings are summarised and how to improve translation of research findings to policy. Research methods tailored to the African context are needed to facilitate better uptake and sustainability in the region.
This project aims to formally develop an approach to translating research findings into policy through summarizing and integrating research findings from different fields. We also aim to recommend methods of improving translation of evidence into policy. Ultimately, through this, we aim to establish a research group and in future a sub-regional centre for the science of evidence synthesis and research translation in Kenya. To our knowledge such a directive or coordinating centre does not yet exist in Kenya.
The objectives of this project are:
1. To summarize the effect and delivery of new and existing interventions on HIV, TB and malaria per national priorities of Kenya.
2. To develop and implement methods of summarizing and integrating research findings and knowledge from different fields.
3. To develop summaries of reviews generated by summarizing and integrating research and knowledge.
4. To communicate and circulate know-how and products of this integrative approach to policy makers.
In the process of achieving this, we will establish a research group in evidence synthesis and research translation in HIV, TB and malaria in Kenya.
This project is timely and has potential for great impact. Under new leadership, there is an explicit shift in the World Health Organization (WHO) to devolve policy making to regional level. The future requires the position of control for evidence synthesis to be firmly implanted in the research infrastructure in Africa. The findings of this project will be useful to policy makers in Kenya who require capacity to integrate research findings from different areas when making decisions.
Technical Summary
While much scientific progress has been made towards development of interventions to aid elimination of the major infectious diseases in Africa-HIV, tuberculosis (TB) and malaria-the incidence and prevalence of these diseases remains high. One barrier to effective control of these diseases is the suboptimal translation of promising interventions and diagnostic tests into policy and practice.
Multiple influencing factors exist between the decision to introduce an intervention and its use in practice. However, currently, synthesis and translation of these different forms of evidence are done as haphazardly if at all, and we need innovative methods to synthesize and integrate these different forms of evidence. We see the broader base of evidence of scale-up being supported by a pipeline of evidence synthesis from different fields to inform technical policy, programmatic guidance and to inform optimum implementation and revisions to existing policies. This is a methodological research project that aims to formally develop a pipeline approach to translating evidence into policy and practice through evidence synthesis and recommend methods for improving translation of evidence into policy and practice. We will develop syntheses of technical evidence on effectiveness or accuracy with application of absolute effects at country level; and develop methods to summarise relevant programmatic (service delivery) information on feasibility, acceptability, economic evaluation and qualitative research at global, regional and national levels. Ultimately, through this project, we aim to establish a research group and a sub-regional directive or coordinating hub for evidence synthesis and research translation in Kenya. To our knowledge no such hub exists in Kenya. This project is timely and has potential for great impact. Under new leadership, there is an explicit shift in the World Health Organization (WHO) to devolve policy making to regional levels.
Multiple influencing factors exist between the decision to introduce an intervention and its use in practice. However, currently, synthesis and translation of these different forms of evidence are done as haphazardly if at all, and we need innovative methods to synthesize and integrate these different forms of evidence. We see the broader base of evidence of scale-up being supported by a pipeline of evidence synthesis from different fields to inform technical policy, programmatic guidance and to inform optimum implementation and revisions to existing policies. This is a methodological research project that aims to formally develop a pipeline approach to translating evidence into policy and practice through evidence synthesis and recommend methods for improving translation of evidence into policy and practice. We will develop syntheses of technical evidence on effectiveness or accuracy with application of absolute effects at country level; and develop methods to summarise relevant programmatic (service delivery) information on feasibility, acceptability, economic evaluation and qualitative research at global, regional and national levels. Ultimately, through this project, we aim to establish a research group and a sub-regional directive or coordinating hub for evidence synthesis and research translation in Kenya. To our knowledge no such hub exists in Kenya. This project is timely and has potential for great impact. Under new leadership, there is an explicit shift in the World Health Organization (WHO) to devolve policy making to regional levels.
Planned Impact
Details of the impact of this study can be found in the pathways to impact statement. In summary, this project has immense potential for impact to stakeholders.
Policy makers will benefit from being engaged in the conduct and dissemination of the project. From the outset of this project we will consult with policy makers at the national level regional and international level to identify priority topics that require evidence on effects and service delivery. In this way, their skills and understanding of the process of evidence synthesis and translation will be enhanced. They will also be better equipped on making effective holistic decisions by incorporating technical and service delivery evidence.
The public will greatly benefit from interventions that are effectively implemented into routine care. Well implemented interventions have a high likelihood of improving program and health outcomes. This project will equip decision makers with new skills in making decisions from an integrated pipeline of evidence incorporating technical and program delivery aspects. In this way improving the implementation and scale-up of interventions effectively.
By engaging with key academic institutions in Kenya through our dissemination activities(local meetings or seminars) we envisage improved capacity in the conduct and use of evidence synthesis. We also foresee future research collaborations and introducing training modules of evidence synthesis where there is none.
There is great interest at the Kenya Medical Research Institute (our partner institution) to build capacity in evidence synthesis which is a critical element in the pipeline of policy relevant research that is currently lacking. Staff and students (PhD students) working in KEMRI can be supported locally by the African Research Leader (ARL) and benefit from the regional (South Africa) and international (UK) collaborations that the ARL has with other evidence synthesis centres. We anticipate that studies conducted by the Centre for Global Health Research (KEMRI-CGHR) that have the potential to influence policy will benefit from better strategies in translation of their findings to inform policy.
This project will not only sharpen the leadership skills of the ARL but develop other leaders in evidence synthesis as well by training one PhD student in methods of evidence synthesis and research translation. We ultimately aim to set up a research group and sub-regional hub in the science of evidence synthesis and research translation in Kenya, building other leaders in evidence synthesis is one way of achieving this goal.
Policy makers will benefit from being engaged in the conduct and dissemination of the project. From the outset of this project we will consult with policy makers at the national level regional and international level to identify priority topics that require evidence on effects and service delivery. In this way, their skills and understanding of the process of evidence synthesis and translation will be enhanced. They will also be better equipped on making effective holistic decisions by incorporating technical and service delivery evidence.
The public will greatly benefit from interventions that are effectively implemented into routine care. Well implemented interventions have a high likelihood of improving program and health outcomes. This project will equip decision makers with new skills in making decisions from an integrated pipeline of evidence incorporating technical and program delivery aspects. In this way improving the implementation and scale-up of interventions effectively.
By engaging with key academic institutions in Kenya through our dissemination activities(local meetings or seminars) we envisage improved capacity in the conduct and use of evidence synthesis. We also foresee future research collaborations and introducing training modules of evidence synthesis where there is none.
There is great interest at the Kenya Medical Research Institute (our partner institution) to build capacity in evidence synthesis which is a critical element in the pipeline of policy relevant research that is currently lacking. Staff and students (PhD students) working in KEMRI can be supported locally by the African Research Leader (ARL) and benefit from the regional (South Africa) and international (UK) collaborations that the ARL has with other evidence synthesis centres. We anticipate that studies conducted by the Centre for Global Health Research (KEMRI-CGHR) that have the potential to influence policy will benefit from better strategies in translation of their findings to inform policy.
This project will not only sharpen the leadership skills of the ARL but develop other leaders in evidence synthesis as well by training one PhD student in methods of evidence synthesis and research translation. We ultimately aim to set up a research group and sub-regional hub in the science of evidence synthesis and research translation in Kenya, building other leaders in evidence synthesis is one way of achieving this goal.
Organisations
- Liverpool School of Tropical Medicine (Lead Research Organisation)
- World Health Organization (WHO) (Collaboration)
- Barcelona Institute for Global Health (Collaboration)
- University of the Witwatersrand (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- THE COCHRANE COLLABORATION (Collaboration)
- UNIVERSITY OF BIRMINGHAM (Collaboration)
- Bond University (Collaboration)
- University of Calabar (Collaboration)
- Kenya Medical Research Institute (Collaboration, Project Partner)
- University College London (Collaboration)
- Yale University (Collaboration)
Publications
Young T
(2020)
Enhancing capacity for clinical practice guidelines in South Africa
in Pan African Medical Journal
Stegeman I
(2020)
Routine laboratory testing to determine if a patient has COVID-19.
in The Cochrane database of systematic reviews
Spies R
(2021)
Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.
in Systematic reviews
Islam N
(2021)
Thoracic imaging tests for the diagnosis of COVID-19.
in The Cochrane database of systematic reviews
Ochodo EA
(2021)
Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.
in The Cochrane database of systematic reviews
Zifodya JS
(2021)
Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.
in The Cochrane database of systematic reviews
Stegeman I
(2022)
Routine laboratory testing to determine if a patient has COVID-19.
in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
Nyanchoka M
(2022)
Implementing essential diagnostics-learning from essential medicines: A scoping review.
in PLOS global public health
Lazarus JV
(2022)
A multinational Delphi consensus to end the COVID-19 public health threat.
in Nature
Engel N
(2022)
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
in The Cochrane database of systematic reviews
Ochodo E.A.
(2022)
Molnupiravir for treating COVID-19
in Cochrane Database of Systematic Reviews
Musekiwa A
(2022)
Modern Biostatistical Methods for Evidence-Based Global Health Research
Ochodo EA
(2022)
Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.
in The Cochrane database of systematic reviews
Stegeman Inge
(2022)
Routine laboratory testing to determine if a patient has COVID-19
in EMERGENCIAS
Albarqouni L
(2023)
Overuse of medications in low- and middle-income countries: a scoping review.
in Bulletin of the World Health Organization
Caleb Kimutai Sagam
(2023)
Quality assessment of clinical practice guidelines in Kenya using the AGREE II tool: a methodological review
Spies R
(2023)
Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.
in Annals of the American Thoracic Society
| Guideline Title | WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease |
| Description | Citation in Clinical Guideline |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.who.int/publications/i/item/9789240100077 |
| Guideline Title | WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 2021 update |
| Description | Citation in Clinical Guideline |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Description | Citation in WHO guidance: WHO Evidence to recommendations: Covid-19 mitigation in the aviation sector |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | • WHO Evidence to recommendations: Covid-19 mitigation in the aviation sector-World Health Organization; 2020- WHO/2019-nCoV/Aviation/evidence/2020.1 I am serving as a methodologist advising on the conduct and translation systematic reviews to inform WHO policy on International travel health in light of Covid-19. These systematic reviews and resulting guidance will influence international travel health for example on questions around quarantining, isolation, testing and contact tracing of travellers. |
| URL | https://www.who.int/publications/i/item/evidence-to-recommendation-covid-19-mitigation-in-the-aviati... |
| Guideline Title | WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. |
| Description | Citation in WHO guideline |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Impact | A systematic review in which I authored; [Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, Schumacher SG, Ochodo E.A, Pai M, Steingart KR. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019 Jun 7; 6:CD009593] informed the WHO guidelines mentioned above. |
| URL | https://www.who.int/publications/i/item/who-consolidated-guidelines-on-tuberculosis-module-3-diagnos... |
| Description | Evidence base to support national recommendation about COVID-19 vaccination in pregnant women |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | The rapid review informed the recommendation for COVID-19 vaccination in pregnant women in Kenya.https://www.health.go.ke/wp-content/uploads/2021/12/DG_Letter_to_CDHS_Vaccination_Final.pdf |
| Description | Participation in developing Kenya's Essential Diagnostics List-Policy |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Global Engagement's Africa and Middle East Teaching Fund 2022/23 |
| Amount | £3,500 (GBP) |
| Funding ID | Collaborative training initiative in clinical trial design and statistics in KEMRI, Kenya. |
| Organisation | University College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 12/2022 |
| End | 07/2023 |
| Description | NIHR Global Health Policy and Systems Research Programme |
| Amount | £56,000 (GBP) |
| Funding ID | NIHR130222 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 11/2020 |
| Description | Systematic review of the first trimester infections impact on maternal pregnancy and infant outcomes |
| Amount | £12,830 (GBP) |
| Organisation | Medicines for Malaria Venture (MMV) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 11/2023 |
| End | 06/2024 |
| Description | Collaboration with Bond University, Australia |
| Organisation | Bond University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | We worked on a scoping reviews and summarised our work about Too much medicine in LMICS in a you tube video o Albarqouni L, Abukmail E, MohammedAli M, Elejla S, Abuelazm M, Shaikhkhalil H, Pathirana T, Palagama S, Effa E, Ochodo E, Rugengamanzi E, AlSabaa Y, Ingabire A, Riwa F, Goraya B, Bakhit M, Clark J, Arab-Zozani M, Alves da Silva S, Pramesh CS, Vanderpuye V, Lang E, Korenstein D, Born K, Tabiri S, Ademuyiwa A, Nabhan A, Moynihan R. Low-Value Surgical Procedures in Low- and Middle-Income Countries: A Systematic Scoping Review. JAMA Netw Open. 2023 Nov 1;6(11): e2342215. doi: 10.1001/jamanetworkopen.2023.42215. o Albarqouni L, Palagama S, Chai J, Sivananthajothy P, Pathirana T, Bakhit M, Arab-Zozani M, Ranakusuma R, Cardona M, Scott A, Clark J, Smith CF, Effa E, Ochodo E, Moynihan R; & the Overdiagnosis and Overuse of Healthcare Services in LMICs Network. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023 Jan 1;101(1):36-61D. doi: 10.2471/BLT.22.288293. I was involved in study selection, data extraction, in drafting the manuscripts and contributing to development of you tube summary https://www.youtube.com/watch?v=IR-hl_Chp98 |
| Collaborator Contribution | Study selection of eligible studies, data extraction, drafting of manuscript. Developing you tube video as a knowledge translation tool (https://www.youtube.com/watch?v=IR-hl_Chp98) |
| Impact | We collaborated on a scoping reviews referenced below. I was one of the senior reviewers. The manuscripts have been published o Albarqouni L, Abukmail E, MohammedAli M, Elejla S, Abuelazm M, Shaikhkhalil H, Pathirana T, Palagama S, Effa E, Ochodo E, Rugengamanzi E, AlSabaa Y, Ingabire A, Riwa F, Goraya B, Bakhit M, Clark J, Arab-Zozani M, Alves da Silva S, Pramesh CS, Vanderpuye V, Lang E, Korenstein D, Born K, Tabiri S, Ademuyiwa A, Nabhan A, Moynihan R. Low-Value Surgical Procedures in Low- and Middle-Income Countries: A Systematic Scoping Review. JAMA Netw Open. 2023 Nov 1;6(11): e2342215. doi: 10.1001/jamanetworkopen.2023.42215. o Albarqouni L, Palagama S, Chai J, Sivananthajothy P, Pathirana T, Bakhit M, Arab-Zozani M, Ranakusuma R, Cardona M, Scott A, Clark J, Smith CF, Effa E, Ochodo E, Moynihan R; & the Overdiagnosis and Overuse of Healthcare Services in LMICs Network. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023 Jan 1;101(1):36-61D. doi: 10.2471/BLT.22.288293. |
| Start Year | 2021 |
| Description | Collaboration with Cochrane COVID-19 Diagnostic Test Accuracy Group |
| Organisation | The Cochrane Collaboration |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | Selecting eligible studies for systematic review, data extraction and drafting of manuscript. Systematic reviews for routine laboratory testing for COVID-19 |
| Collaborator Contribution | Drafting protocol, Methodologic and Statistical support, Study selection, analysis and drafting of manuscript. |
| Impact | Stegeman I, Ochodo EA, Guleid F, Holtman GA, Yang B, Davenport C, Deeks JJ, Dinnes J, Dittrich S, Emperador D, Hooft L, Spijker R, Takwoingi Y, Van den Bruel A, Wang J, Langendam M, Verbakel JY, Leeflang MM; Cochrane COVID-19 Diagnostic Test Accuracy Group. Routine laboratory testing to determine if a patient has COVID-19. Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD013787. doi: 10.1002/14651858.CD013787. PMID: 33211319; PMCID: PMC8078159. De Rop L, Bos DA, Stegeman I, Holtman G, Ochodo EA, Spijker R, Otieno JA, Alkhlaileh F, Deeks JJ, Dinnes J, Van den Bruel A, McInnes MD, Leeflang MM; Cochrane COVID-19 Diagnostic Test Accuracy Group; Verbakel JY. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2. Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015050. doi: 10.1002/14651858.CD015050.pub2. PMID: 39105481; PMCID: PMC11301994. |
| Start Year | 2020 |
| Description | Collaboration with Cochrane Nigeria |
| Organisation | University of Calabar |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | Cochrane Nigeria secureed funding from WHO to concduct sytematic reviews. I was invited as a methodologist for three systematic reviews commisioned by WHO through Cochrane Nigeria. Cochrane Nigeria is nested at the University of Calabar, Nigeria. Invited by Cochrane Nigeria to facilitate a workshop on Diagnostic Accuracy Reviews (21 to 23 Aug 2024) |
| Collaborator Contribution | Securing funding, conducting reviews and drafting reports of systematic reviews. Co-planning the workshop on diagnostic accuracy reviews |
| Impact | o Oduwole OA, Bassey G, Esebanmen G, Shoyinka S, Ohenhen J, Cogo E, Henschke N, Ochodo E, Meremikwu MM. Asymptomatic testing people for SARS-CoV-2 in healthcare facilities: A systematic review. J Public Health Afr. 2025 Jan 3;16(2):581. doi: 10.4102/jphia.v16i2.581. PMID: 39967724; PMCID: PMC11830837. o Effa E, Ita O, Mwankon J, Siyanbade F, Iwomi F, Ochodo E, Villanueva G, Meremikwu M. Post-exposure testing of SARS-COV-2 infection in people in healthcare facilities with SARS-COV-2 transmission: A rapid review (Published in Journal of Public Health in Africa (JPHIA) https://publichealthinafrica.org/index.php/jphia/article/view/623 o Nwachuku N, Arikpo D, Ugo Agbor U, Onyenemerem P, Ochodo E, Smith H, Meremikwu M. Perceptions and factors influencing uptake of diagnostic test interventions for infection prevention and control in the context of Coronavirus 2: a rapid qualitative systematic review (Undergoing copy editing in JPHIA) |
| Start Year | 2022 |
| Description | Collaboration with FIND |
| Organisation | Kenya Medical Research Institute |
| Department | Centre for Global Health Research |
| Country | Kenya |
| Sector | Charity/Non Profit |
| PI Contribution | I served as methodologist to this review commissoined by FIND. Scientific staff from my research group in KEMRI conducted and authored the systematic review. |
| Collaborator Contribution | Partners from FIND served as content experts and contributed to manuscript drafts and revisions. |
| Impact | Publication Otieno JA, Were L, Nyanchoka M, Olwanda E, Mulaku M, Sem X, Kohli M, Markby J, Muriuki A, Ochodo E. Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity. Front Public Health. 2024 Nov 29;12:1439164. doi: 10.3389/fpubh.2024.1439164. PMID: 39678248; PMCID: PMC11638174 |
| Start Year | 2023 |
| Description | Collaboration with Imperial College London: Systematic review and IPD meta-analyses on Malaria |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Providing methodological support on the conduct of the systematic review and meta-analyses and supervising the first author who is a PhD student hired as part of my MRC ARL project team. |
| Collaborator Contribution | Imperial College providing content and statistical expertise as well as guiding the linkage with Malaria researchers who are contributing data to the IPD meta-analyses. |
| Impact | Ongoing: Short protocol reistered on PROSPERO (International Register for Systematic Reviews); Registration number: CRD42021230110 Citation: Caroline Osoro, Eleanor Ochodo, Lucy Okell, Taryn Young, Feiko ter Kuile. Plasmodium falciparum sulfadoxine-pyrimethamine resistance impact on maternal and infant outcomes in intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data (IPD) meta-analysis. PROSPERO 2021 CRD42021230110 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021230110 |
| Start Year | 2020 |
| Description | Collaboration with University College London, UK |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | 1. Collaboration with two Cochrane reviews with Prof Sue Mallet. Professor in diagnostic and prognostic medical statistics, UCL Centre for Medical Imaging Ochodo EA, Olwanda EE, Deeks JJ, Mallett S. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities. Cochrane Database Syst Rev. 2022 Mar 10;3(3):CD013208. doi: 10.1002/14651858.CD013208.pub2. PMID: 35266555; PMCID: PMC8908762. Ochodo EA, Guleid F, Deeks JJ, Mallett S. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less. Cochrane Database Syst Rev. 2021 Aug 12;8(8):CD013207. doi: 10.1002/14651858.CD013207.pub2. PMID: 34383961; PMCID: PMC8406580. 2. Through Prof Sue Mallet, University College London we secured a small grant (3500 GBP) to conduct online and face to face workshops on Evidence-Based Health Care.Course facilitated by funding from the UCL Global Africa and Middle East Teaching Fund Initiative Workshops done: - Clinical trials and hierarchy of evidence: Series of webinars from 19th April 2023 to 3rd May 2023 -Systematic reviews & Meta-analyses: Practical steps. Inperson workshop in Kisumu, Kenya from 26th to 28th June 2023. |
| Collaborator Contribution | Cochrane reviews: Support with methodology and statistical support as well as drafting the manuscripts. Workshops: Securing funding from UCL, collaboration in developing teaching material and aids and in conducting the workshops. |
| Impact | Ochodo EA, Olwanda EE, Deeks JJ, Mallett S. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities. Cochrane Database Syst Rev. 2022 Mar 10;3(3):CD013208. doi: 10.1002/14651858.CD013208.pub2. PMID: 35266555; PMCID: PMC8908762. Ochodo EA, Guleid F, Deeks JJ, Mallett S. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less. Cochrane Database Syst Rev. 2021 Aug 12;8(8):CD013207. doi: 10.1002/14651858.CD013207.pub2. PMID: 34383961; PMCID: PMC8406580. |
| Start Year | 2020 |
| Description | Collaboration with University of Birmingham |
| Organisation | University of Birmingham |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | - University of Birmingham; Biostatistics, Evidence Synthesis, Test Evaluation and Prediction Modelling (BESTEAM) (Coauthored WHO/Cochrane DTA reviews) o Otieno JA, Were L Malesi, Lutje V, Scandrett K, Takwoingi Y, Ochodo EA. Impact of rapid nucleic acid amplification tests for tuberculosis on patient outcomes. Cochrane Database of Systematic Reviews TBD,Issue TBD. Art. No.: CD016194. DOI: 10.1002/14651858.CD016194. This work informed WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis whose draft is ongoing. We prsented findings to the WHO Guideline Development Gropu n Geneva in 2024: Guideline Development Group (GDG) Meeting on NAATS for diagnosis of TB & MDR-TB in Geneva, Switzerland from 6th to 10th May 2024 |
| Collaborator Contribution | We conducted a ssystematic review to inform WHO guidelines referenced above. Conducting reviews to drafting reports and manuscripts. Conducting reviews: Otieno JA, Were L Malesi, Lutje V, Scandrett K, Takwoingi Y, Ochodo EA Search strategy and conducting searches: Lutje V Data collection: Otieno JA, Were L Analysis: Otieno JA, Scandrett K, Takwoingi Y |
| Impact | Manuscript submitted to Cochrane for peer review: Otieno JA, Were L Malesi, Lutje V, Scandrett K, Takwoingi Y, Ochodo EA. Impact of rapid nucleic acid amplification tests for tuberculosis on patient outcomes. Cochrane Database of Systematic Reviews TBD,Issue TBD. Art. No.: CD016194. DOI: 10.1002/14651858.CD016194. |
| Start Year | 2023 |
| Description | Establishment of Cochrane Kenya Entity |
| Organisation | Kenya Medical Research Institute |
| Country | Kenya |
| Sector | Public |
| PI Contribution | Our application to establish a Cochrane Geographical entity in Kenya was approved on 25 Feb 2021 by the Cochrane Collaboration. I am part of the technical working group contributing to its launch and implementation. This is in line with one of the objectives set out by my MRC ARL grant: To establish a research group and hub for evidence synthesis and research translation in Kenya. |
| Collaborator Contribution | The aims of the Cochrane collaboration entity in Kenya include: - To promote evidence based health care practice and policy in Kenya - Build capacity for conducting systematic reviews and meta-analyses in Kenya and wider East African community. - Become a leading advocate for evidence-informed health care in the country and East African region Kemri will be the platform through which Cochrane Kenya will be launced and implemented in Kenya. |
| Impact | This collaboration has been approved and we are preparing for its official launch. |
| Start Year | 2021 |
| Description | Establishment of Cochrane Kenya Entity |
| Organisation | The Cochrane Collaboration |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | Our application to establish a Cochrane Geographical entity in Kenya was approved on 25 Feb 2021 by the Cochrane Collaboration. I am part of the technical working group contributing to its launch and implementation. This is in line with one of the objectives set out by my MRC ARL grant: To establish a research group and hub for evidence synthesis and research translation in Kenya. |
| Collaborator Contribution | The aims of the Cochrane collaboration entity in Kenya include: - To promote evidence based health care practice and policy in Kenya - Build capacity for conducting systematic reviews and meta-analyses in Kenya and wider East African community. - Become a leading advocate for evidence-informed health care in the country and East African region Kemri will be the platform through which Cochrane Kenya will be launced and implemented in Kenya. |
| Impact | This collaboration has been approved and we are preparing for its official launch. |
| Start Year | 2021 |
| Description | Guideline methodologist _ WHO (International Health and Travel Guideline Development Group) |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Guideline methodologist to help in the development of a guideline for syndromic screening of epidemic prone diseases (ongoing) Covid -19 measures in aviation sector-quarantine and isolation |
| Collaborator Contribution | WHO provided logistical support, technical guidance and coordinated the Guideline Development Group meetings |
| Impact | https://www.who.int/publications/i/item/evidence-review-public-health-measures-in-the-aviation-sector-in-the-context-of-covid-19-quarantine-and-isolation---21-may-2021 https://www.who.int/publications/i/item/evidence-to-recommendations-methods-used-for-assessing-health-equity-and-human-rights-considerations-in-covid-19-and-aviation https://www.who.int/publications/i/item/WHO-2019-nCoV-Aviation-Quarantine_and_isolation-Evidence-Annexes-2021.1-eng |
| Start Year | 2020 |
| Description | Lancet Commission for Sustainable Healthcare |
| Organisation | Yale University |
| Department | School of Public Health |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | A commissioner in workpackage 2 : WG2: Clinical Practice Change We are currently conducting a scoping review for this workpackage. |
| Collaborator Contribution | Technical knowledge and expertise. An expected output is a publication ; a Lancet Commission paper published in the Lancet |
| Impact | No outputs yet. An expectd outpu end of 2024 is a submited or published commision paper in the Lancet. |
| Start Year | 2023 |
| Description | Maternal Immunisation Consortium |
| Organisation | University of the Witwatersrand |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Leading workpage on evidence synthesis for Kenya: Evidence synthesis: Burden of disease/Surveillance systems |
| Collaborator Contribution | Conducting scoping reviews for burden of disease and survellance systems for Group B Streptococcal infection (GBS) and Respiratory Syncitial Virus (RSV) |
| Impact | Expected outputs will be systematic and scoing reviews for GBS and RSV |
| Start Year | 2023 |
| Description | Maternal Immunisation Consortium |
| Organisation | University of the Witwatersrand |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Leading workpage on evidence synthesis for Kenya: Evidence synthesis: Burden of disease/Surveillance systems |
| Collaborator Contribution | Conducting scoping reviews for burden of disease and survellance systems for Group B Streptococcal infection (GBS) and Respiratory Syncitial Virus (RSV) |
| Impact | Expected outputs will be systematic and scoing reviews for GBS and RSV |
| Start Year | 2023 |
| Description | The COVID-19 Consensus Statement Panel |
| Organisation | Barcelona Institute for Global Health |
| Country | Spain |
| Sector | Multiple |
| PI Contribution | I was part of a global panel "A multinational Delphi consensus to end the COVID-19 public health threat" that developed a consensus statement to end COVID-19 as a public health threat. This was published in Nature https://www.nature.com/articles/s41586-022-05398-2 |
| Collaborator Contribution | Contributed to the multinational delphi consensus. Professor Jeffrey Lazarus from the Barcelona Institute for Global Health led this initiative. |
| Impact | A publication in Nature https://www.nature.com/articles/s41586-022-05398-2 |
| Start Year | 2022 |
| Description | PhD student engagement with Health practioners in TB referral hopital |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | PhD student relayed results of PhD studies she conducted at the referral hospital in Western Kenya. The results of this study were later published Mulaku MN, Ochodo E, Young T, Steingart KR. Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya. Public Health Action. 2024 Mar 1;14(1):34-39. doi: 10.5588/pha.23.0059. PMID: 38798784; PMCID: PMC11122711. Mulaku MN, Corrie OM, Odero I, Young T, Steingart KR, Ochodo E. Health worker views on pre-treatment loss to follow-up in adults with pulmonary TB in Western Kenya. Public Health Action. 2023 Sep 21;13(3):77-82. doi: 10.5588/pha.23.0016. PMID: 37736575; PMCID: PMC10446661. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Stakeholders' engagement workshop Essential diagnostics: strengthening methods and capacity for evidence based diagnostic practice for effective national programs |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | We held three face to face workshops For national stakeholders (Nairobi, n=30) and county stakeholders (Kisumu n=32 and Siaya County n=41). These workshops were funded through an NIHR developmental award that I was awarded in the tenure of the MRC grant. These workshops were a first step towards establishing an evidence-based diagnostics platform in KEMRI. Workshop Objective To explore gaps in methods and capacity for evidence-informed diagnostic policy and practice in Kenya through engagement with national and county partners and stakeholders in the diagnostic field. Objectives To: 1. Identify areas in diagnostic testing in need for strengthening of evidence to policy practices 2. Identify gaps in evidence to decision pathways between evidence generators and users 3. Explore methods or tools of bridging the gap between evidence generators and users 4. Explore methods of adapting global diagnostic guidelines to national needs 5. Discuss methods of building capacity in evidence-informed diagnostic policy and practice |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.linkedin.com/in/eleanorochodo/recent-activity/shares/ |
| Description | Technical Working Group meetings-Kenya Essential Diagnostics List Guideline |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | About 40 professional practitioners involved in diagnostics from national and county levels were selected by National Public Health Laboratories (NPHLS) Kenya to provide expertise in developing Kenya's first Essential Diagnostics List. We guided this technical working group using an evidence-based process in selecting which essential invitro diagnostics tests to be included in the list/guideline. Kenya's EDL is an adaptation of WHO's EDL. Clinton Health Access Initiative a, a non-governmental organization provided logistical support with financial support from FIND. |
| Year(s) Of Engagement Activity | 2022,2023 |
| Description | Too much medicine series in LMICs |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | We summarised the contents of scoping reviews we did on too much medicine in LMICS to policy makers, health practioners and general public |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.youtube.com/watch?v=IR-hl_Chp98 |